Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

A pharmacokinetic analysis of long-term administration of rubidium chloride.

Meltzer HL.

J Clin Pharmacol. 1991 Feb;31(2):179-84.

PMID:
2010564
2.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
3.

Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.

Moen MD, Lyseng-Williamson KA, Scott LJ.

Drugs. 2009;69(3):361-92. doi: 10.2165/00003495-200969030-00010. Review.

PMID:
19275278
4.

[New vistas on rubidium].

[No authors listed]

Encephale. 1977;3(4):333-56. Review. French.

PMID:
346346
5.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
6.

The significance of excursions above the ADI: duration in relation to pivotal studies.

Walker R.

Regul Toxicol Pharmacol. 1999 Oct;30(2 Pt 2):S114-8. Review.

PMID:
10597624
7.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
8.

Fipronil: environmental fate, ecotoxicology, and human health concerns.

Tingle CC, Rother JA, Dewhurst CF, Lauer S, King WJ.

Rev Environ Contam Toxicol. 2003;176:1-66. Review.

PMID:
12442503

Supplemental Content

Support Center